Cytadren Related Published Studies
Well-designed clinical trials possibly related to Cytadren (Aminoglutethimide)
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. [2008.03.15]
Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a. [2007.12.19]
Other research related to Cytadren (Aminoglutethimide)
Aminoglutethimide but not spironolactone enhances the anticonvulsant effect of some antiepileptics against amygdala-kindled seizures in rats. [2005.07]
Influence of aminoglutethimide and spironolactone on the efficacy of carbamazepine and diphenylhydantoin against amygdala-kindled seizures in rats. [2005.06.15]
Other possibly related research studies
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. [2006.09.20]
Studies of the role of steroid hormone in the regulation of oocyte maturation in cattle. [2006.02.03]
Role of adrenalectomy in ectopic ACTH syndrome. [2005.12]
[Effects of drugs on the adrenal cortex and its tumors] [2006.02]
Implication of glucocorticoid in anti-inflammatory effects of Ro5-4864 in mouse pleurisy induced by carrageenan. [2006.03.13]
The role of glucocorticoids in the uncontrollable stress-induced potentiation of nucleus accumbens shell dopamine and conditioned place preference responses to morphine. [2006.06]
Secondary hormonal therapy for advanced prostate cancer. [2006.01]
Letrozole in the treatment of breast cancer. [2005.07]
Secondary hormonal manipulations in the management of advanced prostate cancer. [2005.06]
Aromatase inhibitors in the treatment of breast cancer. [2005.05]
Evidence for a spinal serotonergic control of the peripheral inflammation in the rat. [2005.04.01]
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. [2007.03.15]
Is pseudo-Cushing's syndrome in a critically ill patient "pseudo"? Hypothesis and supportive case report. [2007.03]
Pharmacological therapy of Cushing's syndrome: drugs and indications. [2007.05]
The discovery and mechanism of action of letrozole. [2007]
Medical management of Cushing disease. [2007]
[Medical treatment for Cushing's syndrome] [2008.01]
Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review. [2007.12]
Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate. [2008.03]
Mono-(2-ethylhexyl) phthalate stimulates basal steroidogenesis by a cAMP-independent mechanism in mouse gonadal cells of both sexes. [2008.05]
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML. [2007.11]
Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome. [2008.06]
Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system. [2008.04]
Aromatase inhibitors: past, present and future in breast cancer therapy. [2008]
Screening of herbal constituents for aromatase inhibitory activity. [2008.09.15]
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. [2009.10.07]
[The medical management of Cushing's syndrome] [2009.04]
History of aromatase: saga of an important biological mediator and therapeutic target. [2009.06]
Steroid biosynthesis inhibitors in the therapy of hypercortisolism: theory and practice. [2008]
Age-dependent role of steroids in the regulation of growth of the hen follicular wall. [2010.02.15]
Drugs in the medical treatment of Cushing's syndrome. [2009.12]
Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: of relevance to clinical understanding? [2010.02.28]
On-chip assay for determining the inhibitory effects and modes of action of drugs against xanthine oxidase. [2010.01.05]
Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus? [2009]
A qualitative systematic review of the evidence base for non-cross-resistance between steroidal and non-steroidal aromatase inhibitors in metastatic breast cancer. [2011.04]
|